Independent Director · TScan Therapeutics, Inc. (TCRX)

Gabriela Gruia, M.D director compensation at TScan Therapeutics: $129K

Fiscal year 2025 director compensation for Gabriela Gruia, M.D at TScan Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 17, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Gabriela Gruia, M.D’s full pay file as a PDF — free

More than this page: up to 10 years of Gabriela’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Gabriela Gruia, M.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

TScan Therapeutics Director Compensation Table · all 5 fiscal years held
In US dollars, as TScan Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$57,499$0$71,623$0$129,122
FY2024$56,500—$307,073$0$363,573
FY2023$46,364—$67,165$0$113,529
FY2022$40,000—$20,086—$60,086
FY2021$40,000—$182,005$0$222,005

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TScan Therapeutics, Inc. DEF 14A filed April 17, 2026, accession 0001193125-26-160304, and prior-year filings. Open the filing on EDGAR.

How this page was built: the TScan Therapeutics, Inc. filed document, accession 0001193125-26-160304. Every figure is read from that document and cited to the page and table it appears in. Filed April 17, 2026.

Get the TScan Therapeutics Board Governance Report

$129,122 Gabriela Gruia, M.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 17, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

TScan Therapeutics pays directors a $40,000 cash retainer and $71,623 in equity.

Committees

FY2025 · as the proxy prints them

Audit · Nominating/Governance · Research and Clinical Development

The rest of the TScan Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Barbara Klencke, M.DIndependent Director$145,779
Garry NicholsonIndependent Director$125,363
Gavin MacBeath, Ph.DDirector—
Katina Dorton, J.D., M.B.AIndependent Director$139,109
R. Keith WoodsIndependent Director$125,265
Stephen Biggar, M.D., Ph.DChair of the Board$162,232

The full TScan Therapeutics compensation record

free company brief

This page is one director within TScan Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order TCRX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report